Bronchial neuroendocrine tumor

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:97287D38.1
Who is this for?
Show terms as
2Active trials31Specialists8Treatment centers

Where are you in your journey?

ℹ
UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Also known as:

Bronchial NET

Clinical phenotype terms— hover any for plain English:

BronchoconstrictionHP:4000007Pulmonary carcinoid tumorHP:0030445Abnormal pulmonary interstitial morphologyHP:0006530Nonproductive coughHP:0031246Elevated circulating growth hormone concentrationHP:0000845Dermatological manifestations of systemic disordersHP:0001005
Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Mar 2026Intratumoral N17350 in Advanced Solid Tumors

Onchilles Pharma Inc — PHASE1, PHASE2

TrialNOT YET RECRUITING
Feb 2026Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute — PHASE2

TrialNOT YET RECRUITING
Feb 2026EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

Essen Biotech — PHASE1, PHASE2

TrialRECRUITING
Jan 2026Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors

Molecular Partners AG — PHASE1, PHASE2

TrialRECRUITING
Dec 2025XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation

Xynomic Pharmaceuticals, Inc. — PHASE1, PHASE2

TrialNOT YET RECRUITING
May 2025A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

Pfizer — PHASE1

TrialACTIVE NOT RECRUITING
Apr 2025Phase I Study of HS-20108 in Participants With Advanced Solid Tumors

Hansoh BioMedical R&D Company — PHASE1

TrialNOT YET RECRUITING
Apr 2025Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies

Elephas

TrialRECRUITING
Jan 2025Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors

Innate Pharma — PHASE1

TrialRECRUITING
Jan 2025Evaluation of a Pragmatic Approach to Adoptive Cell Therapy (ACT) Using an IL2 Analog (ANV419) vs High Dose IL2 After Tumor Infiltrating Lymphocytes (TIL) Therapy in Patients With Melanoma, NSCLC and Cervical Cancer (PragmaTIL)

Vall d'Hebron Institute of Oncology — PHASE2

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Bronchial neuroendocrine tumor.

2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

2 recruitingView all trials with filters →
Phase 21 trial
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Phase 2
Actively Recruiting
PI: Thomas A Hope (Alliance for Clinical Trials in Oncology) · Sites: Birmingham, Alabama; Beverly Hills, California +27 more · Age: 18–99 yrs
View on ClinicalTrials.gov ↗I'm interested →

Specialists

Showing 25 of 31View all specialists →
MD
Matthew Krebs, Dr
Specialist
PI on 7 active trials
GL
Global Clinical Leader
Specialist
PI on 44 active trials4 Bronchial neuroendocrine tumor publications
AM
Andrea B Apolo, M.D.
BETHESDA, MD
Specialist
PI on 9 active trials
SO
Study Official
Specialist
PI on 9 active trials
SM
Steven A Rosenberg, M.D.
Specialist
PI on 19 active trials
JM
James L Gulley, M.D.
BETHESDA, MD
Specialist
PI on 7 active trials
DM
Dawn Pinchasik, MD
PITTSBURGH, PA
Specialist
PI on 2 active trials
PP
Pasi A Janne, MD, PhD
BOSTON, MA
Specialist
PI on 2 active trials
RM
Rahul Aggarwal, MD
Specialist
PI on 6 active trials
SP
Sam Whiting, MD, PhD
Specialist
PI on 3 active trials
JM
Jonathan Strosberg, M.D.
TAMPA, FL
Specialist
PI on 6 active trials
HM
Harriet Kluger, MD
NEW HAVEN, CT
Specialist
PI on 3 active trials
JM
John Fiveash, MD
BIRMINGHAM, AL
Specialist
PI on 5 active trials
JD
Jian Zhang, Doctor
Specialist
PI on 4 active trials
JP
Julian R. Molina, M.D., Ph.D.
Specialist
PI on 1 active trial
BP
Benjamin Thompson, MD, PhD
Specialist
PI on 2 active trials
FD
Fate Trial Disclosure
Specialist
PI on 9 active trials
AM
Abdul Naqash, MD
OKLAHOMA CITY, OK
Specialist
PI on 1 active trial1 Bronchial neuroendocrine tumor publication
PJ
Paul J Jannetto
Specialist
PI on 1 active trial
JC
Joe Y Chang
Specialist
PI on 1 active trial188 Bronchial neuroendocrine tumor publications
AM
Anish Thomas, M.D.
Specialist
PI on 7 active trials
LH
Lily Hu
TAUNTON, MA
Specialist
PI on 3 active trials158 Bronchial neuroendocrine tumor publications
MM
Michael Heinrich, MD
Specialist
PI on 1 active trial
SM
Sven Gogov, MD
Specialist
PI on 3 active trials
AM
Atif Khan, MD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center ↗

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center ↗

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program ↗

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site ↗

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site ↗

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site ↗

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine ↗

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program ↗

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Bronchial neuroendocrine tumor.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Bronchial neuroendocrine tumorForum →

No community posts yet. Be the first to share your experience with Bronchial neuroendocrine tumor.

Start the conversation →

Latest news about Bronchial neuroendocrine tumor

Disease timeline:

New recruiting trial: Register Schweres Asthma - German Asthma Net e.V.

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: RAPA-201 Therapy of Solid Tumors

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: 177Lu-anti-PD-L1 sdAb in Metastatic Solid Tumors

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

New recruiting trial: Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

A new clinical trial is recruiting patients for Bronchial neuroendocrine tumor

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Bronchial neuroendocrine tumor

Are there clinical trials for Bronchial neuroendocrine tumor?

Yes — 2 recruiting clinical trials are currently listed for Bronchial neuroendocrine tumor on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Bronchial neuroendocrine tumor?

25 specialists and care centers treating Bronchial neuroendocrine tumor are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.